Correlation Between 89bio and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both 89bio and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Crispr Therapeutics AG, you can compare the effects of market volatilities on 89bio and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Crispr Therapeutics.
Diversification Opportunities for 89bio and Crispr Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between 89bio and Crispr is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of 89bio i.e., 89bio and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between 89bio and Crispr Therapeutics
Given the investment horizon of 90 days 89bio Inc is expected to generate 1.44 times more return on investment than Crispr Therapeutics. However, 89bio is 1.44 times more volatile than Crispr Therapeutics AG. It trades about 0.02 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.01 per unit of risk. If you would invest 950.00 in 89bio Inc on November 28, 2024 and sell it today you would lose (33.00) from holding 89bio Inc or give up 3.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
89bio Inc vs. Crispr Therapeutics AG
Performance |
| Timeline |
| 89bio Inc |
| Crispr Therapeutics |
89bio and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 89bio and Crispr Therapeutics
The main advantage of trading using opposite 89bio and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| 89bio vs. Madrigal Pharmaceuticals | 89bio vs. Pliant Therapeutics | 89bio vs. Arcellx | 89bio vs. Stoke Therapeutics |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |